Literature DB >> 28111468

Deletion of Ptpn1 induces myeloproliferative neoplasm.

F Jobe1, B Patel2, T Kuzmanovic2, H Makishima2, Y Yang1, B Przychodzen2, R E Hutchison3, K K Bence4, J P Maciejewski2, G Mohi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28111468      PMCID： PMC5967380          DOI： 10.1038/leu.2017.31

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B.

Authors:  M P Myers; J N Andersen; A Cheng; M L Tremblay; C M Horvath; J P Parisien; A Salmeen; D Barford; N K Tonks
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

2.  Critical requirement for Stat5 in a mouse model of polycythemia vera.

Authors:  Dongqing Yan; Robert E Hutchison; Golam Mohi
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

Review 3.  Myeloproliferative disorders.

Authors:  Ross L Levine; D Gary Gilliland
Journal:  Blood       Date:  2008-09-15       Impact factor: 22.113

4.  Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes.

Authors:  F A Asimakopoulos; N J White; E Nacheva; A R Green
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

5.  A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.

Authors:  Emnet Wassie; Christy Finke; Naseema Gangat; Terra L Lasho; Animesh Pardanani; Curtis A Hanson; Rhett P Ketterling; Ayalew Tefferi
Journal:  Br J Haematol       Date:  2014-12-17       Impact factor: 6.998

6.  Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development.

Authors:  Nadia Dubé; Annie Bourdeau; Krista M Heinonen; Alan Cheng; Ailsa Lee Loy; Michel L Tremblay
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.

Authors:  Jungwon Huh; Ramon V Tiu; Lukasz P Gondek; Christine L O'Keefe; Monika Jasek; Hideki Makishima; Ania M Jankowska; Ying Jiang; Amit Verma; Karl S Theil; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Genes Chromosomes Cancer       Date:  2010-04       Impact factor: 5.006

8.  Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.

Authors:  Jay Gunawardana; Fong Chun Chan; Adèle Telenius; Bruce Woolcock; Robert Kridel; King L Tan; Susana Ben-Neriah; Anja Mottok; Raymond S Lim; Merrill Boyle; Sanja Rogic; Lisa M Rimsza; Chrystelle Guiter; Karen Leroy; Philippe Gaulard; Corinne Haioun; Marco A Marra; Kerry J Savage; Joseph M Connors; Sohrab P Shah; Randy D Gascoyne; Christian Steidl
Journal:  Nat Genet       Date:  2014-02-16       Impact factor: 38.330

9.  AKT is a therapeutic target in myeloproliferative neoplasms.

Authors:  I Khan; Z Huang; Q Wen; M J Stankiewicz; L Gilles; B Goldenson; R Schultz; L Diebold; S Gurbuxani; C M Finke; T L Lasho; P Koppikar; A Pardanani; B Stein; J K Altman; R L Levine; A Tefferi; J D Crispino
Journal:  Leukemia       Date:  2013-06-10       Impact factor: 11.528

10.  MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.

Authors:  Stefan Heinrichs; Lillian F Conover; Carlos E Bueso-Ramos; Outi Kilpivaara; Kristen Stevenson; Donna Neuberg; Mignon L Loh; Wen-Shu Wu; Scott J Rodig; Guillermo Garcia-Manero; Hagop M Kantarjian; A Thomas Look
Journal:  Elife       Date:  2013-07-16       Impact factor: 8.140
View more
  4 in total

1.  Biochemical, Enzymatic, and Computational Characterization of Recurrent Somatic Mutations of the Human Protein Tyrosine Phosphatase PTP1B in Primary Mediastinal B Cell Lymphoma.

Authors:  Rongxing Liu; Yujie Sun; Jérémy Berthelet; Linh-Chi Bui; Ximing Xu; Mireille Viguier; Jean-Marie Dupret; Frédérique Deshayes; Fernando Rodrigues Lima
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

2.  Deficiency in Protein Tyrosine Phosphatase PTP1B Shortens Lifespan and Leads to Development of Acute Leukemia.

Authors:  Samantha Le Sommer; Nicola Morrice; Martina Pesaresi; Dawn Thompson; Mark A Vickers; Graeme I Murray; Nimesh Mody; Benjamin G Neel; Kendra K Bence; Heather M Wilson; Mirela Delibegović
Journal:  Cancer Res       Date:  2017-11-09       Impact factor: 12.701

3.  Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation.

Authors:  Samuel A Stoner; Ming Yan; Katherine Tin Heng Liu; Kei-Ichiro Arimoto; Takahiro Shima; Huan-You Wang; Daniel T Johnson; Rafael Bejar; Catriona Jamieson; Kun-Liang Guan; Dong-Er Zhang
Journal:  Blood       Date:  2019-11-14       Impact factor: 25.476

4.  The role of PTP1B (PTPN1) in the prognosis of solid tumors: A meta-analysis.

Authors:  Jiupeng Zhou; Hui Guo; Yongfeng Zhang; Heng Liu; Quanli Dou
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.